Suppr超能文献

基于孕妇年龄和孕中期超声扫描对唐氏综合征进行筛查的六年调查。

Six year survey of screening for Down's syndrome by maternal age and mid-trimester ultrasound scans.

作者信息

Howe D T, Gornall R, Wellesley D, Boyle T, Barber J

机构信息

Wessex Maternal and Fetal Medicine Unit, Princess Anne Hospital, Southampton SO16 5YA.

出版信息

BMJ. 2000 Mar 4;320(7235):606-10. doi: 10.1136/bmj.320.7235.606.

Abstract

OBJECTIVE

To assess the effectiveness of antenatal screening for Down's syndrome by maternal age and routine mid-pregnancy ultrasound scanning.

DESIGN

Retrospective six year survey.

SETTING

Maternity units of a district general hospital.

SUBJECTS

Pregnant women booked for delivery in hospital between 1 January 1993 and 31 December 1998.

MAIN OUTCOME MEASURES

All cases of Down's syndrome occurring in district identified from regional congenital anomaly register and cytogenetic laboratory records. Women's case notes were examined to identify indication for karyotyping, gestation at diagnosis, and outcome of pregnancy.

RESULTS

31 259 deliveries occurred during study period, and 57 cases of Down's syndrome were identified, four in failed pregnancies and 53 in ongoing pregnancies or in neonates. The analysis was confined to ongoing pregnancies or liveborn children. Invasive antenatal tests were performed in 6.6% (2053/31 259), and 68% (95% confidence interval 56% to 80%) of cases of Down's syndrome were detected antenatally, giving a positive predictive value of 1.8%. There were 17 undetected cases, and in seven of these the women had declined an offer of invasive testing. In women aged less than 35 years the detection rate was 53% (30% to 76%). Most of the cases detected in younger women followed identification of ultrasound anomalies.

CONCLUSIONS

The overall detection rate was considerably higher than assumed in demonstration projects for serum screening. As a result, the benefits of serum screening are much less than supposed. Before any new methods to identify Down's syndrome are introduced, such as nuchal translucency or first trimester serum screening, the techniques should be tested in properly controlled trials.

摘要

目的

通过孕妇年龄和常规孕中期超声扫描评估唐氏综合征产前筛查的有效性。

设计

回顾性六年调查。

地点

一家地区综合医院的产科病房。

研究对象

1993年1月1日至1998年12月31日期间在医院预约分娩的孕妇。

主要观察指标

从地区先天性异常登记册和细胞遗传学实验室记录中识别出的该地区所有唐氏综合征病例。检查产妇病历以确定核型分析的指征、诊断时的孕周和妊娠结局。

结果

研究期间共分娩31259例,确诊57例唐氏综合征,4例为妊娠失败,53例为持续妊娠或新生儿。分析仅限于持续妊娠或活产儿。6.6%(2053/31259)的孕妇接受了侵入性产前检查,68%(95%置信区间56%至80%)的唐氏综合征病例在产前被检测出,阳性预测值为1.8%。有17例未被检测出,其中7例孕妇拒绝了侵入性检查。年龄小于35岁的孕妇中,检测率为53%(30%至76%)。年轻女性中检测出的大多数病例是在超声发现异常后确诊的。

结论

总体检测率远高于血清筛查示范项目中的假设。因此,血清筛查的益处远低于预期。在引入任何新的唐氏综合征识别方法(如颈部透明带或孕早期血清筛查)之前,应在适当控制的试验中对这些技术进行测试。

相似文献

5
SURUSS in perspective.透视下的SURUSS。
BJOG. 2004 Jun;111(6):521-31. doi: 10.1111/j.1471-0528.2004.00193.x.
6
SURUSS in perspective.透视下的SURUSS
Semin Perinatol. 2005 Aug;29(4):225-35. doi: 10.1053/j.semperi.2005.05.006.
7
First trimester serum tests for Down's syndrome screening.孕早期唐氏综合征筛查的血清学检测
Cochrane Database Syst Rev. 2015 Nov 30;2015(11):CD011975. doi: 10.1002/14651858.CD011975.
8
Second trimester serum tests for Down's Syndrome screening.孕中期唐氏综合征筛查的血清学检测
Cochrane Database Syst Rev. 2012 Jun 13;2012(6):CD009925. doi: 10.1002/14651858.CD009925.

引用本文的文献

2
5
Urine tests for Down's syndrome screening.唐氏综合征筛查的尿液检测。
Cochrane Database Syst Rev. 2015 Dec 10;2015(12):CD011984. doi: 10.1002/14651858.CD011984.
6
First trimester serum tests for Down's syndrome screening.孕早期唐氏综合征筛查的血清学检测
Cochrane Database Syst Rev. 2015 Nov 30;2015(11):CD011975. doi: 10.1002/14651858.CD011975.
7
Second trimester serum tests for Down's Syndrome screening.孕中期唐氏综合征筛查的血清学检测
Cochrane Database Syst Rev. 2012 Jun 13;2012(6):CD009925. doi: 10.1002/14651858.CD009925.

本文引用的文献

4
Maternal serum screening for Down's syndrome on population basis.基于人群的唐氏综合征母体血清筛查。
Acta Obstet Gynecol Scand. 1997 Oct;76(9):817-21. doi: 10.3109/00016349709024358.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验